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Regulating the choice between neural stem cell main-
tenance versus differentiation determines growth
and size of the developing brain. Here we identify
TGF-b signaling as a crucial factor controlling these
processes.Atearly developmental stages, TGF-bsig-
nal activity is localized close to the ventricular surface
of the neuroepithelium. In the midbrain, but not in the
forebrain, Tgfbr2 ablation results in ectopic expres-
sion of Wnt1/b-catenin and FGF8, activation of Wnt
target genes, and increased proliferation and hori-
zontal expansion of neuroepithelial cells due to short-
ened cell-cycle length and decreased cell-cycle exit.
Consistent with this phenotype, self-renewal of mu-
tant neuroepithelial stem cells is enhanced in the
presence of FGF and requires Wnt signaling. More-
over, TGF-b signal activation counteracts Wnt-in-
duced proliferation of midbrain neuroepithelial cells.
Thus, TGF-b signaling controls the size of a specific
brain area, the dorsal midbrain, by antagonizing
canonical Wnt signaling and negatively regulating
self-renewal of neuroepithelial stem cells.
INTRODUCTION
The central nervous system (CNS) develops from self-renewing,
multipotent neural stem cells that give rise to neural progenitor
cells and eventually to neurons, astrocytes, and oligodendro-
cytes. Neural stem cells can undergo symmetric, nonneurogenic472 Cell Stem Cell 2, 472–483, May 2008 ª2008 Elsevier Inc.divisions that produce two neuroepithelial stem cells and cause
horizontal expansion of the proliferative population (Gotz and
Huttner, 2005). Alternatively, they engage in asymmetric divi-
sions that are associated with the generation of neuronal
progenitors. Moreover, symmetric neurogenic divisions on the
basal side of the neuroepithelium can contribute to rapid expan-
sion of neuronal cells (Haubensak et al., 2004; Noctor et al.,
2004). Thus, the number of neural stem cells and their progeny
critically depends on when the cells switch from symmetric to
asymmetric divisions and on whether or not they exit the cell
cycle (Gotz and Huttner, 2005).
Multiple signaling pathways have been implicated in the regula-
tion of neural stem and progenitor-cell proliferation (Unsicker and
Krieglstein, 2006). Manipulation of the canonical Wnt signaling
pathway leads to dramatic changes in neural stem and progenitor
populations (Kleber and Sommer, 2004). Inparticular, overexpres-
sion of Wnts or persistent activation of the downstream signaling
component b-catenin in the CNS promotes cell-cycle progression
and negatively regulates cell-cycle exit, resulting in horizontal ex-
pansion of precursor populations (Chenn and Walsh, 2002; Meg-
ason and McMahon, 2002). However, in vivo overexpression of
Wnt1 in the midbrain of transgenic mice leads to increased cell
proliferation only in the dorsal, but not in the ventral, midbrain
(Panhuysen et al., 2004), while in cultures of dissociated ventral
midbrain cells Wnt1 is able to enhance proliferation concomitant
with downregulation of cell-cycle inhibitor molecules such as
p27 (Castelo-Branco et al., 2003). Thus, the signaling pathways
regulating neural stem and progenitor-cell proliferation might be
brain area-specific and influenced by the cellular context.
While Wnt and other known signaling factors positively control
expansion of neural stem and progenitor pools, transforming
growth factor b (TGF-b) upregulates cell-cycle inhibitors and
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TGF-b Signaling Regulating Neural Stem Cell Numbercounteracts cell-cycle progression in neuroepithelial cells in
a context-dependent manner, at least in cultures of dissociated
cells or in cortical slice cultures (Seoane et al., 2004;
Siegenthaler and Miller, 2005). TGF-b, which signals through
activation of TGF-b receptor type I and II (Tgfbr1 and Tgfbr2)
and phosphorylation of the signaling mediators Smad2 and
Smad3, elicits multiple cellular responses, including a cytostatic
effect on various cell types (Siegel and Massague, 2003). Al-
though TGF-b has been associated with neuronal differentiation
Figure 1. TGF-b1 Expression and Activation of
TGF-b Signaling in Neuroepithelial Cells Lining
the Ventricular Lumen
(A) TGF-b1 is prominently expressed in the choroid plexus
of forebrain and hindbrain at E12.5.
(B and C) The TGF-b receptor type II (Tgfbr2) is expressed
in virtually all cells of the neuroepithelium. In particular it is
found on 100% ± 0% of all pHH3+ cells.
(D) The intracellular signaling mediators Smad2 and -3 are
phosphorylated specifically in cells at the apical side of the
neuroepithelium and colocalize to a large extent with
pHH3, a marker for cells in M phase (ratio [number of
pSmad2/3+ pHH3+]/[number of pSmad2/3+] in forebrain,
90.7% ± 3.7%; in midbrain, 94.3% ± 2.9%). LV, lateral
ventricle; CP, choroid plexus; 4th V., fourth ventricle;
*mid-/hindbrain boundary (MHB); scale bars, (A and D)
100, (B) 20, and (C) 5 mm.
and survival in the CNS (Brionne et al., 2003;
Farkas et al., 2003; Krieglstein et al., 2000), the
function of TGF-b signaling in neural stem and
progenitor cells in vivo remains to be deter-
mined. Here we show that TGF-b signaling in
cells at the apical neuroepithelium represses
FGF8 and Wnt1 expression as well as canonical
Wnt/b-catenin signaling and, in the presence of
FGF, controls self-renewal of neural stem cells
in a region-specific manner.
RESULTS
Activated Smad2/3 in Mitotic Cells
of the Neuroepithelium
To investigate the role of TGF-b in neuroepithe-
lial cells, we first addressed the expression of
TGF-b signaling components in the developing
brain. At E12.5, the ligands TGF-b1, -2, and -3
were not detectable in the neuroepithelium.
However, the choroid plexus displayed strong
TGF-b1 expression (Figure 1A). The receptor
Tgfbr2 was broadly expressed throughout the
neuroepithelium at E12.5, including in all phos-
phorylated histone H3 (pHH3)-positive M phase
cells (Figures 1B and 1C). Consistent with the
hypothesis that TGF-b1 is released from the
choroid plexus into the cerebrospinal fluid,
phosphorylated (p)Smad2/3 were predomi-
nantly found in cells lining the apical side of
the developing neuroepithelium (Figure 1D). In
contrast, at E12.5, pSmad1/5/8 were not ex-
pressed in most of the neuroepithelium but the roof plate (data
not shown; Ille et al., 2007). The pSmad2/3 localization in cells
close to the ventricle corresponds to the site where neuro-
epithelial stem cells undergo mitosis and presumably choose
between symmetrical nonneurogenic and asymmetrical neuro-
genic cell division (Gotz and Huttner, 2005). Indeed, in both the
developing fore- and midbrain at E12.5, the vast majority of
these pSmad2/3-positive cells were in M phase, as revealed
by coexpression of pHH3 (Figure 1D).Cell Stem Cell 2, 472–483, May 2008 ª2008 Elsevier Inc. 473
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Differentiation in the Forebrain Neuroepithelium
To address the role of TGF-b signaling in the developing fore-
brain in vivo, we used the Cre/loxP system to conditionally
ablate exon4 of the Tgfbr2 gene (Leveen et al., 2002). Emx1-
Cre-mediated recombination resulted in loss of Tgfbr2 protein
in the forebrain neuroepithelium at E12.5 (Figure 2A), consistent
with the previously reported activity of Emx1-Cre in the devel-
oping cortex from around E9.5 onward, before the onset of neu-
rogenesis (Cappello et al., 2006; Iwasato et al., 2000). However,
expression of pSmad2/3 in cells lining the ventricle was not
affected in the forebrain neuroepithelium, pointing to compen-
satory signaling mechanisms (Figure 2B). Accordingly, we did
not observe any overt cortical phenotype in the mutant
(Figure 2C). Notably, the size of the proliferative neuroepithe-
lium was not changed at E18, as visualized by immunohisto-
chemical stainings for the proliferation marker Ki67 and pHH3
as well as for Sox2, a transcription factor associated with main-
tenance of neural progenitor features (Graham et al., 2003) (Fig-
ures 2D and 2E). Likewise, overt differentiation as assayed by
expression of the neuronal marker doublecortin (Dcx) was not
altered in the absence of Tgfbr2 in the developing forebrain
(Figure 2E).
Loss of TGF-b Signaling Leads to Enlargement
of the Dorsal Midbrain
To elucidate the role of TGF-b signaling during mid-/hindbrain
development in vivo, we carried out a Wnt1-Cre-mediated dele-
tion of Tgfbr2 (Ittner et al., 2005; Wurdak et al., 2005). Ablation of
Tgfbr2 in the mid-/hindbrain resulted in undetectable levels
of Tgfbr2 protein. Unlike in the forebrain, a strong reduction of
pSmad2/3 in neuroepithelial cells was observed at E12.5, indi-
cating loss of TGF-b signal transduction to downstream signal-
ing components (Figures 3A and 3B).
In Wnt1-Cre/Tgfbr2 mutants, a specific expansion of the
mutant isthmal and inferior tectal neuroepithelium was first
detectable at E13.5 and prominent at E15, while the anterior dor-
sal and the ventral midbrain appeared unaffected (Figure 3C).
The expansion in the mutant increased with embryonic age, fully
covering the cerebellum at E17 (Figures 3F and 3G). In contrast,
the morphology of the mutant cerebellum appeared normal
throughout embryonic development. At E17, severe deficiencies
in craniofacial structures became apparent, which were due to
ablation of Tgfbr2 in the neural crest (Figure 3G, arrowhead)
(Ittner et al., 2005; Wurdak et al., 2005). Mutant embryos died
before birth, most probably due to anomalies in cardiac neural
crest derivatives (Wurdak et al., 2005).
Figure 2. Continuous Signaling and Normal Proliferation and
Neurogenesis in the Tgfbr2 Mutant Forebrain
Emx1-Cre-mediated conditional ablation of Tgfbr2 in the dorsal telencephalon
leads to loss of Tgfbr2 protein in the dorsal neuroepithelium (A) but has no
effect on Smad2/3 phosphorylation in cells close to the ventricle (B). Hematox-
ylin and eosin (H&E)-stained coronal sections reveal no morphological differ-
ences between control and mutant animals at E18 (C). Staining for Ki67 and
pHH3 shows that proliferation of neuroepithelial cells in the dorsal telenceph-
alon is normal (D). The mutation also has no effect on differentiation, as shown
by the comparison of Sox2 and Dcx expression (E). Scale bars, (A) 50, (B) 35,
(C) 500, and (E) 200 mm.474 Cell Stem Cell 2, 472–483, May 2008 ª2008 Elsevier Inc.
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of Midbrain Neuroepithelial Structures
The isthmus organizer located at the mid-/hindbrain boundary
controls early development and identity of adjacent mid- and
hindbrain areas. At E10.5, the TGF-b pathway, although re-
duced, was still active in a considerable number of cells (relative
number of pSmad2/3-positive cells in control, 100% ± 13.5%;
mutant, 44.2% ± 4.2%). Therefore, the alterations in the Tgfbr2
mutant midbrain unlikely originate from disturbed patterning. In-
deed, no aberrant morphology was observed in the mutant at
E10.5, and at E12.5 we found no change in the expression of
the transcription factors otx2 and Pax2 that mark specific do-
mains in the developing mid-/hindbrain (Broccoli et al., 1999;
Rowitch and McMahon, 1995) (see Figure S1 available with
this article online). Furthermore, the mutant phenotype did not
result from structural disintegration, as both the histological ap-
pearance and the cell density were not changed in the mutant
midbrain neuroepithelium (Figure 3C; data not shown).
Analysis of Ki67 and Sox2 expression at E15 revealed that the
affected area in the Wnt1-Cre/Tgfbr2 mutant midbrain was
largely composed of proliferative neural progenitors (Figures
3D and 3E). Dcx-expressing neuronal cells were present at the
basal side of the mutant neuroepithelium, indicating that differ-
entiation per se was not affected. The neuroepithelial expansion
and in particular the increase in absolute numbers of proliferative
cells might be due to decreased apoptosis or increased relative
proliferation rates at earlier developmental stages. However, no
decrease in the number of apoptotic cells was apparent in the
mutant at E13, E15, and E17 (data not shown). To test whether
absence of TGF-b signaling affects neuroepithelial cell prolifera-
tion at early developmental stages, we analyzed the expression
of Ki67 and pHH3. Although at E12.5 the area of proliferative
neuroepithelial cells was of comparable size in control and
mutant midbrain, quantification of proliferative cells by FACS
revealed that the relative number of Ki67-positive cells was
slightly but significantly enhanced in the mutant (Figure 4A). In
addition, quantification of cells expressing Dcx revealed reduced
numbers of differentiating neurons (Figure 4B). Thus, absence of
TGF-b signaling affects the number of proliferative progenitors.
Different cellular processes could lead to an increased pool of
proliferative cells in the mutant, which over time would produce
the expansion observed in the mutant midbrain neuroepithelium.
For instance, Tgfbr2-deficient cells might undergo a shortened
cell cycle, resulting in more cycling cells at a given time point.
To estimate the cycling time of proliferating cells, we performed
Figure 3. Loss of TGF-b Signaling Results in Neuroepithelial
Expansion in the Dorsal Caudal Midbrain
Wnt1-cre-mediated conditional ablation of Tgfbr2 leads to a loss of both
Tgfbr2 protein expression and pSmad2/3 in the midbrain at E12.5 (A and B).
(C) Morphological analysis of the dorsal midbrain at E15 reveals a lateral ex-
pansion of the caudal dorsal midbrain (open arrow and arrow). (D) Staining
for Ki67/pHH3 and Sox2 (E) demonstrates that the expansion is due to over-
proliferation of undifferentiatied neuroepithelial cells. Dcx-expressing cells
are present at the basal side of both control and mutant midbrains (E). (F
and G) At E17, the drastically expanding mutant midbrain covers the cerebel-
lum (open arrows and arrows). Severe deficiencies can also be observed in
neural crest-derived craniofacial structures (arrowhead). *MHB; dMB, dorsal
midbrain; vMB, ventral midbrain; P, pons; C, cerebellum; CT, cortex; MB,
midbrain; scale bars, (A) 25, (B and E) 200, and (C and G) 500 mm.Cell Stem Cell 2, 472–483, May 2008 ª2008 Elsevier Inc. 475
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TGF-b Signaling Regulating Neural Stem Cell NumberFigure 4. Decreased Cell-Cycle Exit and Shorter Cell-Cycle Length
Are the Cellular Effects Leading to Midbrain Enlargement
(A and B) (A) At E12.5, before apparent morphological defects, the fraction of
proliferating cells in the dorsal midbrain is increased as shown by Ki67 FACS
analysis (control, 35.9% ± 2.6%; mutant, 41.5% ± 0.5%; n = 4). Quantification
of Dcx-expressing cells (B) revealed a reduced number of differentiating
neurons per area (control, 3.7 ± 0.4; mutant, 2.5 ± 0.1; n = 3).
(C) The percentage of the total fraction of proliferating cells present in S phase
(S/Ki67; mean of control is defined as 100%) is significantly increased in mu-
tants (control, 100% ± 7.1%; mutant, 114.6% ± 2.0%; n = 4), indicating
a shorter cell-cycle time in mutant dorsal midbrains. Cumulative BrdU-labeling
experiments at E12.5 confirmed the shortened cell-cycle time in mutants (con-
trol, 964 min; mutant, 747 min; correlation coefficients r2(co), 0.999, and r2(mt),
0.987).
(D) Cell-cycle exit was addressed by determining the fraction of cells that had
incorporated BrdU (BrdU+) when pulsed 20 hr before analysis but were not
proliferative anymore (Ki67) at the time of analysis. A strong reduction in476 Cell Stem Cell 2, 472–483, May 2008 ª2008 Elsevier Inc.cell-cycle FACS analysis in combination with Ki67 staining of dis-
sociated cells from control and mutant dorsal midbrains
(Figure 4C). S phase stays relatively constant in mammalian cells,
while the length of G1 regulates cell-cycle time (Calegari and Hutt-
ner, 2003; Takahashi et al., 1995). Hence, the relative fraction of
proliferating cells that are in S phase at a specific time point is
higher in cell populations with shorter cell-cycle time. At E10.5,
proliferation and the fraction of cells in S phase was similar in mu-
tant and control embryos (data not shown). However, in the dorsal
midbrain at E12.5, the relative fraction of proliferative cells in S
phase was significantly increased in the mutant as compared to
the control (Figure 4C). To further confirm changes in cell-cycle
length in mutant cells, we assessed the cell-cycle time (TC) by cu-
mulative BrdU labeling experiments at E12.5 (Nowakowski et al.,
1989). The cell-cycle time of mutant neuroepithelial cells was
drastically reduced (Figure 4C, right panel). Thus, Tgfbr2-mutant
neuroepithelial cells divide with a shorter cell-cycle time than do
control cells.
The increase of proliferative cells in the mutant midbrain could
also be caused by mutant neuroepithelial cells preferentially
choosing to stay in rather than to exit the cell cycle. To
address this possibility, the fraction of cells dividing after BrdU
pulse labeling 20 hr earlier was determined. Cells that had left
the cell cycle were identified as BrdU positive and Ki67 negative,
while cells that remained in the cell cycle were BrdU positive and
Ki67 positive. At E12.5, a highly significant decrease of cells ex-
iting the cell cycle was detectable in the mutant as compared to
the control (Figure 4D), indicating that TGF-b signal inactivation
in dorsal midbrain not only affects cell-cycle length of dividing
neural progenitors but also the choice whether or not to exit
the cell cycle. In mutants, as in controls, the vast majority
of the cells that left the cell cycle adopted a neuronal fate
(Figure 4E).
Ectopic Expression of FGF and Wnt Signaling
Components and Activation of Positive Cell-Cycle
Regulators upon TGF-b Signal Inactivation
Canonical Wnt signaling via the intracellular signaling compo-
nent b-catenin regulates cell-cycle exit and expansion of
progenitor cells in the developing cortex and other brain areas
(Kleber and Sommer, 2004). To test whether midbrain neuroepi-
thelial expansion in the absence of TGF-b signaling is linked to
Wnt signaling, we first examined the expression of wnt1 mRNA
in control and mutant dorsal midbrains by in situ hybridization
at E12.5. Before overt morphological changes, wnt1 was ectop-
ically expressed (Figure 5B) in the domain displaying decreased
cell-cycle exit (Figure 4D). Canonical Wnt signaling leads to
stabilization of b-catenin and its translocation into the nucleus
(Reya and Clevers, 2005). Immunostaining combined with confo-
cal microscopy demonstrated nuclear accumulation of b-catenin
specifically in cells populating the region of ectopic wnt1 in E12.5
mutant embryos (Figure 5C). Corresponding control cells lacked
cell-cycle exit was observed at E12.5 (control, 24.0% ± 1.3%; mutant, 9.5% ±
1.3%; n = 3).
(E) The vast majority of the cells that exited the cell cycle (BrdU+ Ki67) adopted
a neuronal fate and expressed Dcx (control, 90.6% ± 4.5%; mutant, 88.1% ±
3.1%). Scale bar, 20 mm. *p < 0.05, **p < 0.01.
Data are shown as mean ± standard deviation of the mean (SD).
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TGF-b Signaling Regulating Neural Stem Cell NumberFigure 5. Ectopic FGF Expression and Wnt Signaling Concomitant
with Increased Expression of Positive Cell-Cycle Regulators
TGF-b-signal inactivation in the dorsal caudal midbrain leads to ectopic ex-
pression domains of wnt1 (A) and fgf8 (B). Confocal microscopy of the regionnuclear b-catenin and exhibited only the form of the protein
associated with cell-cell adhesion complexes. Furthermore,
western blot analysis confirmed the presence of activated b-cat-
enin in mutant dorsal midbrains, while it was undetectable in
controls (Figure 5D). In culture of neural progenitor cells, the
effect of canonical Wnt signaling on proliferation is dependent
on the presence of FGF (Israsena et al., 2004). Consistent with
Wnt/b-catenin acting in concert with FGF signaling, fgf8 mRNA
was ectopically expressed in the Tgfbr2-deficient dorsal mid-
brain in the domain of ectopic wnt1 expression (Figure 5A).
Thus, TGF-b signal inactivation in the mid-/hindbrain region re-
sults in increased wnt1 and fgf8 expression concomitant with nu-
clear accumulation of activated b-catenin in the dorsal midbrain.
To further investigate the molecular mechanisms possibly
underlying altered cell-cycle progression in Tgfbr2 mutant mid-
brainneuroepithelialcells,weperformedreal-timePCRwithapar-
ticular focus on cell-cycle regulators. The cell-cycle inhibitors p21
and p27 are known targets of TGF-b signal activity (Seoane et al.,
2004; Siegenthaler and Miller, 2005). However, in the Tgfbr2
mutant midbrain, neither the expression of p21 nor of p27 was
changed (data not shown). Likewise, expression of the negative
cell-cycle regulators PTEN, p19, and p53 was unaltered in the
Tgfbr2 mutant midbrain as compared to the control. In contrast,
expression of specific positive cell-cycle regulators was upre-
gulated in the mutant (Figures 5E and 5F). In particular, the ex-
pression of CyclinD2 and CyclinD1 was significantly increased.
CyclinE expression, however, was unaltered. Of the cyclin
interaction partners, Cdk4 and a Cdk2 isoform displayed signifi-
cantly enhanced expression in the mutant. These data point
to selective activation of cell-cycle-promoting factors upon in-
activation of TGF-b signaling. Moreover, the transcriptional
activation of known Wnt targets such as CyclinD1 supports the
hypothesis that increased proliferation in neuroepithelial cells
lacking Tgfbr2 is mediated by derepressed Wnt signaling.
Absence of TGF-b Signaling Affects Self-Renewal
Capacity, but Not Multipotency, of Neural Stem
Cells in the Presence of FGF
The horizontal expansion and shortening of the cell-cycle length
in Tgfbr2-deficient dorsal midbrain conceivably reflects an influ-
ence of TGF-b on symmetric stem cell self-renewal, rather than
on proliferation of progenitorsor cell-lineage decision.To address
on the cellular level how loss of TGF-b signaling might influence
neural stem and progenitor cells, we cultured neurospheres
(Reynolds and Rietze, 2005) derived from dissociated dorsal
midbrains of E12.5 and E15 embryos. Recombination efficiency
within neurospheres was assessed by X-Gal staining taking
advantage of the Rose26 Cre reporter allele (Soriano, 1999),
revealing efficient recombination in virtually all control and mutant
showing ectopic wnt1 expression reveals nuclear accumulation of b-catenin
(C). (D) Western blot analysis demonstrates upregulation of activated b-catenin
(b-catact) in the mutant dorsal midbrain at E12.5. Real-time PCR analysis
reveals that CyclinD1 (control, 1.0 ± 0.1; mutant, 1.7 ± 0.2; n = 5), CyclinD2
(control, 1.0 ± 0.1; mutant, 1.3 ± 0.1; n = 5), Cdk4 (control, 1.0 ± 0.04; mutant,
1.2 ± 0.1; n = 5), and a transcriptional variant of Cdk2 (control, 1.0 ± 0.2;
mutant, 1.8 ± 0.2; n = 5) are specifically upregulated in mutant tissue (E and
F). Scale bars, (B) 100 and (C) 10 mm. *p < 0.05, **p < 0.01, data are presented
as mean ± SEM.Cell Stem Cell 2, 472–483, May 2008 ª2008 Elsevier Inc. 477
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nin expression observed in the mutant midbrain in vivo (Figures
5C and 5D), activated b-catenin levels were augmented in Tgfbr2
mutant neurospheres derived from E12.5 and from E15 midbrains
(Figure 6B, Figure S2B). Intriguingly, increased formation of
mutant spheres occurred only in the presence of FGF, but not in
medium containing EGF without FGF (Figure 6C, Figure S2C).
Thus, TGF-b signal inactivation leads to canonical Wnt signal
activation in neural stem/progenitor cells and to increased sphere
formation specifically in the presence of FGF.
In order to compare the self-renewal capacity of Tgfbr2mutant
and control stem/progenitor cells, primary spheres were propa-
gated at clonal density. The number of secondary spheres per
primary sphere as well as the number of spheres obtained upon
serial propagation was significantly increased in mutant cultures,
suggesting a higher number of self-renewing neural stem/progen-
Figure 6. Increased Sphere Formation and Self-
Renewal but Normal Differentiation Potential of
Neuroepithelial Stem Cells
(A) Cells isolated from E12.5 control and mutant dorsal
midbrains give rise to X-Gal-positive neurospheres.
(B) Western blot analysis demonstrates increased level of
activated b-catenin (b-catact) in secondary neurospheres.
(C) Neurosphere assays at E12.5 show a significantly in-
creased number of mutant primary spheres (n = 5) in
FGF-containing but not in FGF-deficient/EGF-containing
medium (numbers are indicated as spheres per 10,000
cells plated).
(D and E) The mutant neuroepithelial cells display in-
creased formation of secondary spheres per primary
sphere (n = 5). The successive increase in the number of
clonally derived mutant spheres over seven serial pas-
sages (pa) shows the enhanced self-renewal capacity of
mutant neural stem cells (n = 3).
(F) Similar differentiation potential of control and mutant
secondary spheres was observed at E15 (n = 3). Markers
used included the following: GFAP for astrocytes (A), O4
for oligodendrocytes (O), and b3-tubulin for neurons (N).
TP, tripotent (positive for all three markers).
(G) Loss of TGF-b signaling does not alter percentage of
neurons (N) versus oligodendrocytes (O) within single differ-
entiated secondary spheres (n = 3). The majority of control
and mutant sphere cells (85%) are astrocytes. **p < 0.01.
Data are shown as mean ± SD.
itor cells present in mutant dorsal midbrains at
E12.5 as well as at E15 (Figures 6D and 6E;
Figure S2D). Strikingly, mutant sphere formation
steadily increased with each successive pas-
sage, while the number of control spheres re-
mained relatively constant at significantly lower
levels over six passages and decreased toward
zero in the seventh passage. These data indicate
not only a greater number of neural stem cells in
primary mutant tissue but also enhanced self-
renewal of mutant neural stem cells over time.
Besides their ability to self renew, the key
characteristic of neural stem cells is tripotency
(Reynolds and Rietze, 2005). Upon differentia-
tion, about 70% of control and mutant spheres
were tripotent, giving rise to neurons, oligodendrocytes, and
astrocytes, and no significant difference in the overall differenti-
ation potential of control and mutant spheres was observed
(Figure 6F). Furthermore, cell-lineage specification within individ-
ual differentiating spheres was not changed, since similar per-
centages of neurons, oligodendrocytes, and astrocytes were
found in mutant and control secondary spheres (Figure 6G).
We next addressed whether loss of TGF-b signaling not only
affects the self-renewal of stem cells but also the proliferation
of stem cell-derived transient amplifying progenitor cells. Since
increased proliferation of the latter correlates with sphere size,
we compared the diameters of control versus mutant neuro-
sphere populations. Interestingly, the average diameter of mu-
tant primary and secondary spheres derived from either E12.5
or E15 dorsal midbrains was not altered as compared to control
spheres (Figures S2E–S2G). Additionally, control and mutant478 Cell Stem Cell 2, 472–483, May 2008 ª2008 Elsevier Inc.
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passages (Figure S2H), indicating that in culture proliferation of
transient amplifying progenitor cells is not affected by the
absence of TGF-b signaling.
TGF-b Decreases the Sphere-Forming Potential
and Counteracts Wnt Signal-Dependent Proliferation
of Midbrain Neuroepithelial Stem Cells
Since loss of TGF-b signaling significantly enhanced self-renewal
of mutant neural stem cells in the presence of FGF, increased
TGF-b may elicit the opposite effect. Intriguingly, the number of
primary spheres and of secondary spheres per primary sphere
derived from E12.5 wild-type dorsal midbrain cells cultured in
FGF-containing medium was significantly reduced in the pres-
ence of TGF-b1, while sphere sizes remained unaffected
(Figure 7A, Figure S2G). Moreover, TGF-b1 did not affect the po-
tential of E12.5 midbrain neuroepithelial cells to differentiate into
Figure 7. TGF-b Reduces Stem Cell Self-
RenewalandCounteractsWnt-InducedPro-
liferation without Affecting Fate Decisions
(A) The number of E12.5 wild-type primary spheres
and secondary spheres per primary sphere in
cultures treated with TGF-b1 is significantly de-
creased as compared to untreated cultures (n = 6).
(B) Neuronal versus glial differentiation of neuro-
epithelial midbrain cells is comparable in the
presence or absence of TGF-b1 (GFAP for glial,
bIII-tubulin [bIII] for neuronal differentiation). The
graph illustrates the staining intensity of marker-
positive cells in mass culture (n = 3).
(C) TGF-b counteracts Wnt-induced proliferation
of midbrain neuroepithelial cells in clonal cultures
(n = 3; cell death in all conditions <10%).
(D) Increased primary sphere formation as well as
increased self-renewal of Tgfbr2mutant cells is re-
duced to control levels in the presence of sFRP1,
a soluble inhibitor of the Wnt pathway (n = 3). Num-
bers of primary spheres are indicated as spheres
per 10,000 cells plated. For all panels, *p < 0.05,
**p < 0.01, data are shown as mean ± SD.
(E) Model of the signaling network with TGF-b,
Wnt, and FGF regulating the balance between
self-renewal and differentiation of midbrain neural
stem cells.
neuronal and glial cells (Figure 7B).
Hence, TGF-b was able to decrease the
number of sphere-forming units as well
as the self-renewal capacity of midbrain
neuroepithelial cells without affecting
cell-fate decisions and progenitor-cell
proliferation. In contrast, sphere forma-
tion by forebrain cells at E12.5 was not
significantly affected by TGF-b1 (control,
103.8 ± 19.6 spheres/10,000 cells; TGF-
b added, 81.5 ± 7.4 spheres), confirming
the brain area-specific effect of TGF-b
signaling, observed in vivo.
Both the Tgfbr2 mutant dorsal midbrain
in vivo and neurosphere cultures derived
from mutant midbrains displayed elevated levels of activated b-
catenin (Figures 5C, 5D and 6B; Figure S2B). These findings raise
thequestionofwhether theeffectsobserveduponTGF-b inactiva-
tion might reflect cellular responses elicited by Wnt ligands that
are normally counteracted by TGF-b. To address whether TGF-b
can suppress mitotic Wnt activity in the presence of FGF, neuro-
epithelial cells dissociated from wild-type dorsal midbrains were
cultured at clonal density in FGF-containing medium on either
Wnt1-expressing cells or on control feeder layers. In accordance
with previous findings (Ille et al., 2007), the number of cells per
clone was significantly increased by Wnt1 as compared to control
conditions (Figure 7C). This Wnt1-mediated mitotic effect was re-
duced to control levels upon treatment with TGF-b1, demonstrat-
ing that TGF-b efficiently antagonizes Wnt-induced proliferation
of neuroepithelial cells in the presence of FGF. To further test
the antagonism of TGF-b and Wnt in controlling stem cell num-
bers, Tgfbr2 mutant and control neurospheres were treated withCell Stem Cell 2, 472–483, May 2008 ª2008 Elsevier Inc. 479
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itor of Wnt signaling (Finch et al., 1997). Intriguingly, addition of
sFRP1 diminished the number of mutant primary spheres and of
secondary per primary spheres to control levels (Figure 7D).
These data demonstrate that increased self-renewal upon
TGF-b signal inactivation is due to Wnt signal activation in the
mutant cells.
DISCUSSION
Stem cell maintenance, progenitor proliferation, and timely
differentiation play important roles in regulating brain size.
Though it has become evident that distinct signaling pathways
are implicated in these processes (Unsicker and Krieglstein,
2006), little is known about functional interactions and integra-
tion of distinct signaling events. Here, we demonstrate that
TGF-b signal activity is very prominent in dividing cells close to
the apical surface of the developing neuroepithelium. In the dor-
sal midbrain, inactivation of TGF-b signaling causes decreased
cell-cycle exit and increased self-renewal of neuroepithelial cells
without affecting their multipotency and capacity for neuronal
differentiation. As a consequence, TGF-b signal inactivation
results in a drastic horizontal expansion of the mutant dorsal
midbrain. In contrast, inactivation of Tgfbr2 in the forebrain or
ventral midbrain does not alter neuroepithelial cell proliferation,
revealing brain area-specific control mechanisms of cell-cycle
progression. Intriguingly, in the dorsal midbrain, loss of TGF-b
signaling causes region-specific, ectopic expression of activated
Wnt/b-catenin and of Wnt target genes involved in promoting
cell-cycle progression. In addition, TGF-b is sufficient to counter-
act Wnt-induced proliferation of midbrain neuroepithelial cells,
while Wnt signal inhibition reverts the effect of TGF-b sig-
nal inactivation on stem cell self-renewal. Taken together, our
results provide new evidence for a functional crosstalk between
TGF-b and Wnt signaling in controlling the fate switch of neural
stem cells from nonneurogenic cell division to differentiation.
TGF-b Signaling Negatively Regulates Self-Renewal
of Midbrain Neuroepithelial Stem Cells
Several findings presented here support the hypothesis that
TGF-b signaling influences specifically nonneurogenic stem
cell expansion in the dorsal midbrain rather than neurogenic pro-
genitor proliferation. Upon inactivation of TGF-b signaling, prolif-
eration in the Sox2-positive neuroepithelium of the mutant dorsal
midbrain was enhanced as compared to the control, concomitant
with horizontal expansion of neuroepithelial structures, while
apoptosis was not changed. Normally, the transition from proli-
ferative divisions to neurogenic divisions is accompanied by
cell-cycle lengthening (Calegari et al., 2005). However, prolifera-
tive cells from the mutant dorsal midbrain displayed a shorter
cell-cycle length compared to their control counterparts (Figures
4C and 4D). These data suggest that at least a fraction of Tgfbr2
mutant neuroepithelial cells fail to efficiently switch from symmet-
ric proliferative divisions to asymmetric neurogenic divisions and
eventual differentiation. In agreement with this model, cell-cycle
exit was significantly reduced upon TGF-b signal inactivation.
This is reminiscent of the phenotype observed in neural progeni-
tor cells expressing constitutively active b-catenin, which also
display preferential cell-cycle re-entry (Chenn and Walsh, 2002).480 Cell Stem Cell 2, 472–483, May 2008 ª2008 Elsevier Inc.Hence, our findings indicate that TGF-b promotes the choice of
neuroepithelial cells to leave the cell cycle rather than to re-enter
a new round of stem cell division, leading to more proliferative
symmetric divisions and finally to the lateral expansion of the
stem cell pool in Tgfbr2 mutants.
The neurosphere assay provides a quantitative in vitro model
system to study stem and progenitor-cell proliferation, self-re-
newal, and multipotency (Reynolds and Rietze, 2005). Proliferat-
ing progenitor cells represent the most frequent cell type within
a sphere, and thus the proliferation rate of these cells will cru-
cially determine cell number and sphere size. Tgfbr2 mutant
compared to control neurosphere cultures showed a difference
neither in the average sphere size nor in the size distribution of
primary and secondary neurosphere populations. Additionally,
mutant and control neurospheres contained comparable num-
bers of cells, indicating similar rates of progenitor-cell prolifera-
tion. This is in contrast to inactivation of other regulators of neural
stem/progenitor cells, such as Notch1, Bmi-1, or Pten, which
leads to an increased number of self-renewing stem cells in
neurosphere assays, but in addition also to altered sphere
size (Groszer et al., 2001; Molofsky et al., 2003; Ohtsuka et al.,
2001).
Although neurosphere size and cell number was not changed
upon TGF-b signal inactivation, dissociated cells isolated from
mutant dorsal midbrains at E12.5 gave rise to significantly more
neurospheres as compared to control cells. Complementary to
these results, the presence of TGF-b in wild-type cultures
strongly decreased primary and secondary neurosphere forma-
tion. Given that a neural stem cell has a greater self-renewal
potential than a transient amplifying progenitor cell (Reynolds
and Rietze, 2005), serial passage experiments of clonally derived
neurospheres are an appropriate tool to compare mutant versus
control stem cell activity over time. Neurosphere formation in
mutant cultures increased with each successive passage, while
it occurred at a significantly lower level in control cultures, dem-
onstrating the role of TGF-b in controlling self-renewal.
Importantly, neither TGF-b signal activation nor inactivation
influenced multipotency of midbrain neural stem cells. This is
in contrast to loss of the neural stem cell factor Bmi-1, which
alters the composition of differentiated cells derived from neural
progenitors (Zencak et al., 2005). Thus, TGF-b does not sup-
press neural stem cell features by instructively or selectively
promoting the generation of a specific cell lineage but rather
by counteracting stem cell expansion.
On the molecular level, the expansion of mutant midbrain neu-
roepithelium is preceded by ectopic expression of wnt1, nuclear
b-catenin, and fgf8. Additionally, TGF-b1 is sufficient to counter-
act Wnt1-induced mitotic activity in the presence of FGF. Loss of
TGF-b signaling also leads to elevated Wnt signaling in mutant
neurosphere cultures in medium containing FGF. Moreover, inhi-
bition of the Wnt pathway by addition of sFRP1 to these cultures
demonstrates the functional requirement of Wnt signaling in the
control of stem cell numbers in Tgfbr2 mutants. In agreement
with our results, ectopic overexpression of Wnt1 at the mid-/
hindbrain boundary enhanced proliferation of neuroepithelial
precursor cells by shortening the cell-cycle length (Panhuysen
et al., 2004). This resulted in enlargement of the dorsal midbrain,
a phenotype much resembling the enlargement of Tgfbr2 mutant
midbrain. Similar to Tgfbr2 deletion, Wnt1 misexpression did not
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regional identity of the mid-/hindbrain area.
Inactivation of TGF-b signaling and subsequent region-
specific, ectopic Wnt/b-catenin activation was concomitant
with significantly increased expression of known Wnt targets
such as CyclinD1, CyclinD2 (http://www.stanford.edu/rnusse/
wntwindow.html), and the corresponding cyclin-dependent
kinases Cdk4 and Cdk2. Surprisingly, the expression levels of
known TGF-b targets such as p21 and p27 were unaltered, rais-
ing the possibility that the primary function of TGF-b is to repress
Wnt signaling. Although the mechanism underlying this antago-
nistic crosstalk remains to be elucidated, it appears to involve
regulation of Wnt signaling on both the transcriptional and
posttranscriptional level. The latter is indicated by our finding
(Figure 7C) that TGF-b is able to efficiently counteract prolifera-
tion of midbrain neuroepithelial cells treated with Wnt1 in culture.
This might involve the signaling components Smad andb-catenin
that have been shown to physically associate and functionally
interact in other systems (Kleber and Sommer, 2004). In addition,
fgf8 is upregulated in Tgfbr2 mutant dorsal midbrains, and the
Wnt-dependent increase in stem cell self-renewal is seen in the
presence of FGF, but not EGF. Possibly FGF-dependent, but
not EGF-dependent, neural stem cells are TGF-b responsive.
Alternatively, FGF, but not EGF, signaling acts in concert with
Wnt to promote stem cell self-renewal in the absence of
TGF-b signaling. This is in agreement with earlier findings that
the mitogenic effects of Wnt/b-catenin on neural stem and pro-
genitor cells are FGF dependent (Israsena et al., 2004).
Brain Area-Specific TGF-b Signal Interpretation
While Tgfbr2 is broadly expressed, the ligands TGF-b1, -2, and -3
were not detectable in the developing neuroepithelium at the time
point of overt Smad2/3 phosphorylation. However, TGF-b1 is
strongly expressed in the choroid plexus. Although this needs
to be addressed experimentally, the data are consistent with
the idea that TGF-b is released into the ventricle to activate
Smad2/3 specifically in cells close to the ventricle throughout
the entire developing brain. Nonetheless, Tgfbr2 inactivation in
neuroepithelial stem cells leads to a brain area-specific pheno-
type. This cannot simply be explained by unequal recombination
efficiencies of Emx1-Cre and Wnt1-Cre, which were both higher
than 98% in forebrain and midbrain neural stem cells, respec-
tively. Although the mechanisms underlying the area-specific
effects of TGF-b signal inactivation remain to be elucidated,
they can either be elicited by a region-specific extracellular envi-
ronment or by cell-intrinsic differences. There is evidence for both
of these to occur. First, midbrain, but not forebrain, sphere forma-
tion was affected by TGF-b1. This differential responsiveness
likely involves the forkhead transcription factor FoxG1 that is spe-
cifically expressed in the forebrain neuroepithelium around the
developmental stages when we observe pSmad2/3 expression
in cells lining the ventricle. Similar to midbrain cells in our study,
isolated forebrain progenitor cells acquired responsiveness to
growth-inhibitory TGF-b activity, but only upon loss of FoxG1
(Seoane et al., 2004). Second, cell-extrinsic cues specific for
the forebrain might compensate for the loss of Tgfbr2, as phos-
phorylation of Smad2/3 is not altered in the mutant forebrain.
Activin and nodal bind to a different type II receptor (ActRII)
than TGF-b but share the same intracellular signaling mediatorsSmad2 and Smad3 (Shi and Massague, 2003). Interestingly,
activin is specifically expressed in the forebrain but not the dorsal
midbrain neuroepithelium at the stage when the Tgfbr2 mutant
phenotype becomes apparent in the midbrain (Feijen et al.,
1994). Based on the combined data, we propose a model in
which the activity of broadly supplied ventricular TGF-b is region-
ally modulated according to brain area-specific growth require-
ments that in neuroepithelial stem cells of the caudal dorsal
midbrain involve a signaling network of TGF-b, Wnt, and FGF.
EXPERIMENTAL PROCEDURES
Generation of Tgfbr2 Mutant Mice and In Vivo Fate Mapping
Generation of mutant animals and genotyping was done as described
(Cappello et al., 2006; Wurdak et al., 2005). The penetrance of the phenotype
described in this study was 100% in Tgfbr2 mutant animals. Littermates carry-
ing one wild-type allele or lacking Cre displayed no overt phenotype and were
used as controls. All animal experiments were approved by the veterinary
office of the Canton of Zurich, Switzerland.
Staining Procedures
For immunohistochemistry, antigen retrieval was performed by incubating par-
affin sections in a pressure cooker in Citrate Buffer (pH 6) for 5 min at 110C.
Polyclonal primary antibodies used were pHistone-H3 (rabbit, Upstate), Tgfbr2
(rabbit, Santa Cruz Biotechnology), Tgfb1 (rabbit, Santa Cruz Biotechnology),
Dcx (guinea pig, Chemicon), Sox2 (rabbit, Chemicon), and Pax2 (rabbit,
Zymed Laboratories). Monoclonal primary antibodies used were pSmad2
(CST, clone 138D4, most probably also recognizes pSmad3), pHistone-H3
(CST, clone 6G3), Ki67 (DAKO, clone TEC-3), BrdU (Sigma, clone BU-33),
and b-catenin (BD Transduction Laboratories, clone 14/b-catenin). Stainings
against Tgfbr2 and pSmad2/3 were done with the TSA Plus System from
PerkinElmer according to the manufacturer’s instructions. TUNEL staining
was performed following the producer’s guidelines (Roche Diagnostics).
In situ hybridization with riboprobes to wnt1 (gift of R. Nusse), fgf8 (Tanaka
et al., 1992), and otx2 (gift of J. Rossant) were done as described (Wurdak
et al., 2005). For all stainings, at least three embryos per stage and genotype
were analyzed.
Real-Time PCR
Total RNA was isolated from dorsal midbrains of E12.5 embryos using TRIZOL
(Invitrogen) according to the manufacturer’s instructions. Of total RNA, 2 mg
was used for each cDNA synthesis using Ready-To-Go You-Prime First-
Strand Beads (Amersham). Quantitative real-time PCR was performed with
the ABI Prism 7000 Sequence Detection System (Applied Biosystems) using
the Master SYBR Green kit (ABgene). Results were normalized using the
expression levels of ribosomal 18S rRNA. Primers used for real-time PCR
are specified in Table S1.
Cell-Cycle FACS Analysis
Cells were isolated from dorsal midbrains of E10.5 (n = 3) and E12.5 (n = 4)
embryos and split 1:1 in order to use one half of cells for fixation with 70% eth-
anol for 30 min and the other half for fixation with 4% PFA in PBS and 0.01%
saponin for 10 min, respectively. After fixing, the cells were resuspended in
FACS buffer (PBS containing 1% FCS, 5 mM EDTA). The DNA content of
ethanol-fixed cells was stained with propidium iodide (1 mg/ml) for 10 min
and used for FACS analysis. Ki67 staining (mouse, Abcam) was done on the
PFA-fixed cells in FACS buffer containing 0.01% (v/v) saponin.
BrdU Labeling
BrdU labeling was performed by i.p. injection of 10 ml/g body weight of the
pregnant mother of 10 mM BrdU solution (Roche). For the analysis of the
cell-cycle exit, mice were injected 20 hr before they were sacrificed. Two sec-
tions from each animal were analyzed and averaged. For determination of the
cell-cycle length, animals were injected at E12.5 for 30 (n = 3), 165 (n = 3), and
255 min (n = 5). Four sections per animal were analyzed and averaged. LinearCell Stem Cell 2, 472–483, May 2008 ª2008 Elsevier Inc. 481
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equals 1/TC (Nowakowski et al., 1989).
Cell Culture
Neurosphere cultures were prepared as described (Ille et al., 2007) in the pres-
ence or absence of 0.5 ng/ml TGF-b1 (R&D), 20 ng/ml FGF (R&D), 20 ng/ml
EGF (R&D), and 3.5 mg/ml sFRP1 (R&D) as indicated. Only spheres with a
diameter >50 mm were counted. In order to induce differentiation, secondary
neurospheres were plated onto coverslips precoated with poly-L-lysine
(Sigma) in DMEM/F12 supplemented with B-27. After 5 days, neurospheres
were fixed in 4% PFA and stained with primary antibodies against GFAP
(rabbit, DAKO), b3-tubulin (chicken, abcam), and O4 (mouse, Chemicon).
To perform adhesive clonal cell-culture assays, dorsal midbrain cells were
isolated from embryonic rat brains at E14 (equivalent to mouse E12.5) and
cultured as described (Ille et al., 2007). Cells were either exposed to Wnt1-
producing or to control feeder layers, with or without TGF-b1 (5 ng/ml).
Western Blotting
Dorsal midbrains were removed from E12.5 or E15 embryos, and the cell
extracts were used for western blot analysis (Wurdak et al., 2005). Primary
antibodies were against actin (Chemicon) and dephosphorylated (activated)
b-catenin (Upstate, clone 8E7).
Statistical Analysis
Results are shown as mean ± standard deviation of the mean (SD). Statistical
analysis (two-tailed unpaired Student’s t test; calculation of SD) were done
with Microsoft Excel.
SUPPLEMENTAL DATA
Supplemental Data include two figures and one table and can be found with
this article online at http://www.cellstemcell.com/cgi/content/full/2/5/472/
DC1/.
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